Screening, the cornerstone of chemotherapy.

Screening, the cornerstone of chemotherapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Screening, the cornerstone of chemotherapy. Abstract Text:

Screening, the cornerstone of chemotherapy. Publishing Authors By Initials

For similar natural sciences: science: research: research design research abstracts see: natural sciences: science: research: research design research

PUBMED ID PMID:

MEDLINE DATE:

Screening, the cornerstone of chemotherapy. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer chemotherapy reports. Part 2

VOLUME: 3

Page Numbers: 309-13

Journal Abbreviation:

ISSN: 0069-0120

DAY: 29

MONTH: Nov

YEAR: 1972

Screening, the cornerstone of chemotherapy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7607106

Screening, the cornerstone of chemotherapy. Keywords Mesh Terms:

KEYWORDS: Research Design

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Screening, the cornerstone of chemotherapy. Information

Substance Name: Antineoplastic Agents

Registry Number: 0

Grant and Affiliation Information for Screening, the cornerstone of chemotherapy.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Chemother Rep 2

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Screening, the cornerstone of chemotherapy Related Publications

• "Compression paddle gallstone": artifact of standard radiographic accessory.
• Altered sensitivity of a hamster plasmacytoma to cytosine arabinoside (NSC-63878).
• Antiviral chemotherapy as an indicated adjunct to cancer chemotherapy.
• CT evaluation of thickened esophageal walls.
• Concepts for treatment of micrometastases developed in murine systems.
• Development of Friend leukemia virus in spleen and plasma of Swiss mice.
• Ectopic cranium: postoperative abdominal wall skull fragments.
• Effect of 1,3-bis(2-chlorethyl)-1-nitrosourea (NSC-409962) and nitrogen mustard (NSC-762) on kinetic behavior of cultured L1210 leukemic cells.
• Experimental evaluation of potential anticancer agents. VII. Cross resistance of alkylating agent-resistant neoplasms.
• Experimental evaluation of potential anticancer agents. XI. Quantitative response of the Sa180 system to deoxypyridoxine.
• Experimental evaluation of purine antagonists as anticancer agents.
• Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
• Growth requirements and biologic characteristics of leukemia L1210 cells in culture.
• Historical development and future promise of the nitrosoureas as anticancer agents.
• Laboratory study of the epidemiology of poliomyelitis.
• Rationale for perioperative anticancer treatment.
• Recovery of poliomyelitis virus from the throat during the incubation period.
• Screening, the cornerstone of chemotherapy.
• Some observations on the carcinostatic activity of Eponate on Fortner hamster plasmacytoma.
• Spontaneous AK leukemia (lymphoma) as a model for human leukemias and lymphomas.
• Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
• The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis.